Emergence of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone in a Japanese child, demonstrating multiple divergent strains in Japan
- 107 Downloads
In 2008 we isolated methicillin-resistant Staphylococcus aureus (MRSA) from an 11-month-old Japanese girl who lived in Saitama, Japan, and suffered from cellulitis of the lower thigh and sepsis. The MRSA (strain NN47) belonged to multilocus sequence type (ST) 8 and exhibited spa363 (t024), agr1, staphylococcal cassette chromosome mec (SCCmec) type IVa, and coagulase type III. It was positive for Panton–Valentine leukocidin (PVL) and the arginine catabolic mobile element (ACME). Pulsed-field gel electrophoresis (PFGE) demonstrated that the MRSA was the USA300 clone, which is the predominant community-acquired MRSA (CA-MRSA) in the US. Strain NN47 was divergent, in terms of the spa type and patterns of PFGE and plasmids, from the USA300-0114 type strain or USA300 strain NN36, previously isolated from a visitor (Indian girl) from the US. Strain NN47 was resistant to erythromycin, in addition to β-lactam agents (e.g., oxacillin). These data demonstrate the first emergence of the USA300 clone in Japanese children who have never been abroad and have had no contact with foreigners (and therefore, the first USA300 spread in Japan), and also emergence of multiple divergent strains of the USA300 clone in Japan. Because the USA300 clone is highly transmissible and virulent, surveillance of the USA300 clone is needed.
KeywordsCommunity-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) Panton–Valentine leukocidin (PVL) Arginine catabolic mobile element (ACME) Child
We thank L. K. McDougal and L. L. McDonald for the USA300 type strain.
- 6.Yamamoto T, Dohmae S, Saito K, Otsuka T, Takano T, Chiba M, et al. Molecular characteristics and in vitro susceptibility to antimicrobial agents, including the des-fluoro(6) quinolone DX-619, of Panton–Valentine leucocidin-positive methicillin-resistant Staphylococcus aureus isolates from the community and hospitals. Antimicrob Agents Chemother. 2006;50:4077–86.CrossRefPubMedGoogle Scholar
- 12.Clinical and Laboratory Standards Institute. Performance standard for antimicrobial susceptibility testing; 18th informational supplement, vol. 28, no. 1, M100-S18. Wayne: Clinical and Laboratory Standards Institute; 2008.Google Scholar
- 15.Larsen AR, Goering R, Stegger M, Lindsay JA, Gould KA, Hinds J, et al. Two distinct clones of methicillin-resistant Staphylococcus aureus (MRSA) with the same USA300 pulsed-field gel electrophoresis profile: a potential pitfall for identification of USA300 community-associated MRSA. J Clin Microbiol. 2009;47:3765–8.CrossRefPubMedGoogle Scholar